Identification | Back Directory | [Name]
Broussonin E | [CAS]
90902-21-9 | [Synonyms]
Broussonin E 2-[3-(3-Hydroxy-4-methoxyphenyl)propyl]-5-methoxyphenol Phenol,2-[3-(3-hydroxy-4-methoxyphenyl)- propyl]-5-methoxy- | [Molecular Formula]
C17H20O4 | [MDL Number]
MFCD20274991 | [MOL File]
90902-21-9.mol | [Molecular Weight]
288.34 |
Hazard Information | Back Directory | [Description]
Broussonin E could suppress inflammation by modulating macrophages activation state via inhibiting the ERK and p38 MAPK and enhancing JAK2-STAT3 signaling pathway, and can be further developed as a promising drug for the treatment of inflammation-related diseases such as atherosclerosis. | [target]
TNF-α | p38 MAPK | ERK | JAK | STAT |
|
Company Name: |
BioBioPha Co., Ltd.
|
Tel: |
0871-65217109 13211707573; |
Website: |
http://www.biobiopha.com |
|